A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid

Published 2012 View Full Article

Authors

Keywords

Journal

BIOORGANIC & MEDICINAL CHEMISTRY

Volume 21, Issue 1, Pages 42-61

Publisher

Elsevier BV

Online

2012-11-11

DOI

10.1016/j.bmc.2012.11.003

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BIOORGANIC & MEDICINAL CHEMISTRY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.